Opti Capital Management, LP Quant / Systematic

CIK: 0001738654 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $897,093 (0.1% shares, 99.9% debt)

Holdings (34)

— TERADYNE INC 10.8%

Value ($000) $96,468 Shares 25,439,000 Est. Cost $4.52 Unrealized —

— NUANCE COMMUNICATIONS INC 8.0%

Value ($000) $71,808 Shares 38,565,000 Est. Cost $1.66 Unrealized —

— DOCUSIGN INC 8.0%

Value ($000) $71,505 Shares 22,933,000 Est. Cost $3.03 Unrealized —

— SAREPTA THERAPEUTICS INC 7.6%

Value ($000) $68,028 Shares 27,809,000 Est. Cost $2.40 Unrealized —

— 8X8 INC NEW 7.4%

Value ($000) $66,450 Shares 45,450,000 Est. Cost $1.63 Unrealized —

— NEW RELIC INC 5.3%

Value ($000) $47,510 Shares 48,091,000 Est. Cost $1.22 Unrealized —

— RAPID7 INC 5.1%

Value ($000) $45,898 Shares 21,000,000 Est. Cost $2.44 Unrealized —

— ZILLOW GROUP INC 4.7%

Value ($000) $42,499 Shares 14,200,000 Est. Cost $2.99 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 4.1%

Value ($000) $36,963 Shares 38,801,000 Est. Cost $1.77 Unrealized —

— FIREEYE INC 3.8%

Value ($000) $34,398 Shares 34,833,000 Est. Cost $2.09 Unrealized —

— EXACT SCIENCES CORP 3.7%

Value ($000) $33,096 Shares 17,483,000 Est. Cost $1.89 Unrealized —

— VERINT SYS INC 3.6%

Value ($000) $32,605 Shares 29,740,000 Est. Cost $2.30 Unrealized —

— AVAYA HLDGS CORP 2.7%

Value ($000) $24,619 Shares 23,500,000 Est. Cost $0.95 Unrealized —

— SYNAPTICS INC 2.7%

Value ($000) $24,117 Shares 17,500,000 Est. Cost $2.37 Unrealized —

— LUMENTUM HLDGS INC 2.4%

Value ($000) $21,497 Shares 13,000,000 Est. Cost $1.65 Unrealized —

— REALPAGE INC 2.3%

Value ($000) $20,894 Shares 10,000,000 Est. Cost $2.09 Unrealized —

— RAMBUS INC DEL 1.7%

Value ($000) $15,260 Shares 13,500,000 Est. Cost $1.57 Unrealized —

— NUTANIX INC 1.6%

Value ($000) $14,052 Shares 13,873,000 Est. Cost $1.99 Unrealized —

— CYTOKINETICS INC 1.6%

Value ($000) $14,021 Shares 6,500,000 Est. Cost $4.95 Unrealized —

— IONIS PHARMACEUTICALS INC 1.5%

Value ($000) $13,223 Shares 12,900,000 Est. Cost $1.03 Unrealized —

— RETROPHIN INC 1.3%

Value ($000) $12,082 Shares 11,905,000 Est. Cost $1.47 Unrealized —

— JAZZ INVESTMENTS I LTD 1.3%

Value ($000) $11,705 Shares 10,909,000 Est. Cost $2.00 Unrealized —

— PTC THERAPEUTICS INC 1.2%

Value ($000) $10,952 Shares 8,500,000 Est. Cost $2.51 Unrealized —

— OMEROS CORP 1.1%

Value ($000) $9,942 Shares 9,200,000 Est. Cost $1.93 Unrealized —

— APELLIS PHARMACEUTICALS INC 0.9%

Value ($000) $8,414 Shares 5,000,000 Est. Cost $1.68 Unrealized —

— VONAGE HLDGS CORP 0.9%

Value ($000) $8,179 Shares 7,505,000 Est. Cost $1.08 Unrealized —

— OPKO HEALTH INC 0.9%

Value ($000) $7,844 Shares 6,200,000 Est. Cost $2.12 Unrealized —

— VOCERA COMMUNICATIONS INC 0.8%

Value ($000) $7,069 Shares 5,000,000 Est. Cost $1.41 Unrealized —

— FIREEYE INC 0.8%

Value ($000) $6,870 Shares 5,634,000 Est. Cost $1.22 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 0.7%

Value ($000) $5,961 Shares 5,300,000 Est. Cost $0.99 Unrealized —

— INTERCEPT PHARMACEUTICALS IN 0.5%

Value ($000) $4,250 Shares 7,000,000 Est. Cost $0.71 Unrealized —

— RADIUS HEALTH INC 0.4%

Value ($000) $3,975 Shares 4,407,000 Est. Cost $0.82 Unrealized —

— PROOFPOINT INC 0.4%

Value ($000) $3,932 Shares 3,500,000 Est. Cost $1.12 Unrealized —

T AT&T INC 0.1%

Value ($000) $1,007 Shares 35,000 Est. Cost $15.38 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	TERADYNE INC	25,439,000	$96,468	10.8%	$4.52	—	NOTE 1.250%12/1	880770AG7
—	NUANCE COMMUNICATIONS INC	38,565,000	$71,808	8.0%	$1.66	—	DBCV 1.000%12/1	67020YAK6
—	DOCUSIGN INC	22,933,000	$71,505	8.0%	$3.03	—	NOTE 0.500% 9/1	256163AB2
—	SAREPTA THERAPEUTICS INC	27,809,000	$68,028	7.6%	$2.40	—	DBCV 1.500%11/1	803607AB6
—	8X8 INC NEW	45,450,000	$66,450	7.4%	$1.63	—	NOTE 0.500% 2/0	282914AB6
—	NEW RELIC INC	48,091,000	$47,510	5.3%	$1.22	—	NOTE 0.500% 5/0	64829BAB6
—	RAPID7 INC	21,000,000	$45,898	5.1%	$2.44	—	NOTE 1.250% 8/0	753422AB0
—	ZILLOW GROUP INC	14,200,000	$42,499	4.7%	$2.99	—	NOTE 0.750% 9/0	98954MAE1
—	SUPERNUS PHARMACEUTICALS INC	38,801,000	$36,963	4.1%	$1.77	—	NOTE 0.625% 4/0	868459AD0
—	FIREEYE INC	34,833,000	$34,398	3.8%	$2.09	—	NOTE 1.625% 6/0	31816QAD3
—	EXACT SCIENCES CORP	17,483,000	$33,096	3.7%	$1.89	—	NOTE 1.000% 1/1	30063PAA3
—	VERINT SYS INC	29,740,000	$32,605	3.6%	$2.30	—	NOTE 1.500% 6/0	92343XAA8
—	AVAYA HLDGS CORP	23,500,000	$24,619	2.7%	$0.95	—	NOTE 2.250% 6/1	05351XAB7
—	SYNAPTICS INC	17,500,000	$24,117	2.7%	$2.37	—	NOTE 0.500% 6/1	87157DAD1
—	LUMENTUM HLDGS INC	13,000,000	$21,497	2.4%	$1.65	—	NOTE 0.250% 3/1	55024UAB5
—	REALPAGE INC	10,000,000	$20,894	2.3%	$2.09	—	NOTE 1.500%11/1	75606NAB5
—	RAMBUS INC DEL	13,500,000	$15,260	1.7%	$1.57	—	NOTE 1.375% 2/0	750917AG1
—	NUTANIX INC	13,873,000	$14,052	1.6%	$1.99	—	NOTE 1/1	67059NAB4
—	CYTOKINETICS INC	6,500,000	$14,021	1.6%	$4.95	—	NOTE 4.000%11/1	23282WAA8
—	IONIS PHARMACEUTICALS INC	12,900,000	$13,223	1.5%	$1.03	—	NOTE 0.125%12/1	462222AB6
—	RETROPHIN INC	11,905,000	$12,082	1.3%	$1.47	—	NOTE 2.500% 9/1	761299AB2
—	JAZZ INVESTMENTS I LTD	10,909,000	$11,705	1.3%	$2.00	—	NOTE 1.500% 8/1	472145AD3
—	PTC THERAPEUTICS INC	8,500,000	$10,952	1.2%	$2.51	—	NOTE 3.000% 8/1	69366JAB7
—	OMEROS CORP	9,200,000	$9,942	1.1%	$1.93	—	NOTE 6.250%11/1	682143AE2
—	APELLIS PHARMACEUTICALS INC	5,000,000	$8,414	0.9%	$1.68	—	NOTE 3.500% 9/1	03753UAB2
—	VONAGE HLDGS CORP	7,505,000	$8,179	0.9%	$1.08	—	NOTE 1.750% 6/0	92886TAJ1
—	OPKO HEALTH INC	6,200,000	$7,844	0.9%	$2.12	—	NOTE 4.500% 2/1	68375NAD5
—	VOCERA COMMUNICATIONS INC	5,000,000	$7,069	0.8%	$1.41	—	NOTE 1.500% 5/1	92857FAB3
—	FIREEYE INC	5,634,000	$6,870	0.8%	$1.22	—	NOTE 0.875% 6/0	31816QAF8
—	IRONWOOD PHARMACEUTICALS INC	5,300,000	$5,961	0.7%	$0.99	—	NOTE 0.750% 6/1	46333XAF5
—	INTERCEPT PHARMACEUTICALS IN	7,000,000	$4,250	0.5%	$0.71	—	NOTE 2.000% 5/1	45845PAB4
—	RADIUS HEALTH INC	4,407,000	$3,975	0.4%	$0.82	—	NOTE 3.000% 9/0	750469AA6
—	PROOFPOINT INC	3,500,000	$3,932	0.4%	$1.12	—	NOTE 0.250% 8/1	743424AF0
T	AT&T INC	35,000	$1,007	0.1%	$15.38	0.0%	COM	00206R102